AI Mathematician: Towards Fully Automated Frontier Mathematical Research

Large Reasoning Models (LRMs) have made significant progress in mathematical capabilities in recent times. However, these successes have been primarily confined to competition-level problems. In this work, we propose AI Mathematician (AIM) framework, which harnesses the reasoning strength of LRMs to support frontier mathematical research. We have identified two critical challenges of mathematical research compared to competition, {\it the intrinsic complexity of research problems} and {\it the requirement of procedural rigor}. To address these challenges, AIM incorporates two core strategies: an exploration mechanism to foster longer solution paths, and the pessimistic reasonable verification method to ensure reliability. This early version of AIM already exhibits strong capability in tackling research-level tasks. We conducted extensive experiments across several real-world mathematical topics and obtained promising results. AIM is able to autonomously construct substantial portions of proofs and uncover non-trivial insights within each research area. These findings highlight the potential of LRMs in mathematical discovery and suggest that LRM-based agent systems could significantly accelerate mathematical research in the future.

Variational and Explanatory Neural Networks for Encoding Cancer Profiles and Predicting Drug Responses

Human cancers present a significant public health challenge and require the discovery of novel drugs through translational research. Transcriptomics profiling data that describes molecular activities in tumors and cancer cell lines are widely utilized for predicting anti-cancer drug responses. However, existing AI models face challenges due to noise in transcriptomics data and lack of biological interpretability. To overcome these limitations, we introduce VETE (Variational and Explanatory Transcriptomics Encoder), a novel neural network framework that incorporates a variational component to mitigate noise effects and integrates traceable gene ontology into the neural network architecture for encoding cancer transcriptomics data. Key innovations include a local interpretability-guided method for identifying ontology paths, a visualization tool to elucidate biological mechanisms of drug responses, and the application of centralized large scale hyperparameter optimization. VETE demonstrated robust accuracy in cancer cell line classification and drug response prediction. Additionally, it provided traceable biological explanations for both tasks and offers insights into the mechanisms underlying its predictions. VETE bridges the gap between AI-driven predictions and biologically meaningful insights in cancer research, which represents a promising advancement in the field.